Oppenheimer Asset Management Inc. Bio Rad Laboratories, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 2,871 shares of BIO stock, worth $874,535. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,871
Previous 2,817
1.92%
Holding current value
$874,535
Previous $686,000
0.87%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BIO
# of Institutions
436Shares Held
19.2MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$767 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$562 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$472 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$304 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$263 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.5B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...